|
Mexican OTC Drugmaker Warned for Missing Test Records, GMP Documents
Compania Internacional de Comercio (CIC), a Mexican maker of OTC topical ointments and gels, has been handed an FDA warning letter for straying from the agency’s good manufacturing practice (GMP) regulations, including failing to document analytical tests and GMP procedures.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives